Member Info for Trickymatters

They updated their website in January 2024.

They didn't raise as much as they wanted though did they?

Directors buying is not proof of anything. They could be accused of insider trading if they buy when they know they have to enter into dispute over a payment which is then swiftly resolved due to taking such action and followed by an announcement of forthcoming phase 2 trials.

Strange that there's more buying now than there's been for some time. Could be a disaster, could be a catalyst to get things done in line with their agreement and trying to assert some control as the junior partner. Not happy obviously. Probably not as unhappy as Staclica investors if this goes pear shaped.

Not brave enough to buy more just now but will dive in if phase 2 trials are confirmed. Blimey.

Yes, I am holding too. Hope to see another RNS next week confirming an arrangement to pay and next steps for phase 2 trials. Otherwise it's over for EVG and probably very bad news indeed for Staclica and their directors could be facing direct challenge in court. Seems too far fetched. Think they are just trying it on for a deferred payment. EVG RNSed that they were very pleased with the trial outcome in August.

Yes DS Flat. If Stalicla pull out now that will impact on the whole legitimacy of their platform DEPI. The updated site, Jan 2024 states that DEPI correctly predicted the response for STP2 candidates based on their assessed data in clinical trials. So if they've changed their mind based on trials DEPI isn't any good/ Stalicla have misled the market in their recent series 16 fundraiser. Very unlikely. Think they might be wanting to move the goal posts on the payment because they didn't raise as much as they wanted but as the website says STP2 will enter trials this year. So still committed. Hope they resolve this quickly. Both firms reputations are on the line. Staclica has much more to lose.The Novartis deal could be compromised and they could face serious consequences if they have misled the market.

I'm adding too if it falls an iota tomorrow. In answer to your question Richard Clements we're expecting news on settling outstanding debts owed to the company and other plans to sort out liquidity, anytime. Results are due in March after that. We already know that they will be very good. Read the December RNS'.

The fT has a story today about the decline of hedge funds. Says investors have pulled £150billion from them this year because they are doing so badly. Not surprising considering the dumb moves they're making.

Helikon are going to be embarrassed this year. Got burnt on ITM and they're going to be absolutely frazzled by PFC. Oh dear, oh dear🙃

Yep. 30p coming any minute now. Share price cop anyone? I'm going for 31.5p. 35 by Friday cop.

Just taken £8k. Looking brighter. Not long before news on finance I'd have thought. Could drop anytime. Results will follow and they will be brilliant. Shorters are flirting with real danger here. Don't feel sorry for them but it won't be pretty for them so I'm not gloating either. They're making a big mistake. Hey ho.

We won't end up red. But yeah, weak response today. Plenty of time for it to pick up before the third license lands. Don't know why everyone leaves it to the last minute before buying and pay more for the privilege. Hey ho.

Who do we think it is then? There are a few household names here in this field already. Quick google search brought this up. I guess at some point someone with connections in this field will find out who it is.

https://evmagazine.com/top10/top-10-companies-electrifying-commercial-vehicles

Evgen are working on a treatment not a test. Don't compare apples with umm, peas. They are about to start phase 2 trials for ASD this year. OBD have done their own clinical trials and will be maintaining records of the tests they're selling through their clinic I expect. They haven't done any large scale credible trials or been approved by regulatory authorities have they? So this is why they aren't selling at scale.

Evgen have been granted orphan status by the FDA for one product in their pipeline. Phase 2 trials for ASD are a big deal. Working with Staclica who are working with Novartis is a big deal. In Aim, PIs are 'the market' for a long time. We aren't on the radar. If/when this next stage is announced we will get on the radar with PIs and IIs.

Licenses worth over £30 billion to ORCA. Not much response yet. I'm in because we need energy security atm with Saudi pulling production, US prioritising the US for energy and Russia being boycotted and starting wars for no reason.

Hope we don't start sliding into a load of crap monologues about renewables not working. They are working and we have to transition. We're driving with oil right now until we can afford electric cars. Not happening overnight is it? 2035/40 maybe?

15p now on Google finance live prices. Looking good.

Looks like it. The Guardian only just got the story tonight.

Quick off the mark FrazerJohn. Thank you.😊 That should kick things off tomorrow!

I'm sorry you bought in too early CJ. I am not angry with anyone. You are a troll though. Maybe just don't be one anymore. New Year's resolution?

In case anyone missed this last week. GLA